Tesamorelin 5mg + Ipamorelin 5mg is a dual-peptide research formulation containing equal amounts of two structurally distinct compounds used in laboratory studies involving growth hormone signaling pathways.
Tesamorelin is a synthetic analog of growth hormone-releasing factor (GRF), while Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue. Together, these compounds provide a defined research blend for controlled biochemical, receptor, and peptide-signaling studies.
Each vial contains 5mg of Tesamorelin and 5mg of Ipamorelin, for a total peptide content of 10mg.